Candida albicans proteinases and host/pathogen interactions

Cellular Microbiology

Volumn 6, Issue 10, 2004, Pages 915-926

  Naglik, Julian ^a   Albrecht, Antje ^b   Bader, Oliver ^b   Hube, Bernhard ^b  

^a KING'S COLLEGE LONDON   (United Kingdom)

^b ROBERT KOCH INSTITUTE   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ASPARTIC PROTEINASE; FUNGAL PROTEIN; GENE PRODUCT; PROTEINASE;

CANDIDA ALBICANS; CANDIDIASIS; CELL ADHESION; ENZYME SYNTHESIS; FUNGAL VIRULENCE; FUNGUS HYPHAE; GENE EXPRESSION; GENE SWITCHING; HOST PATHOGEN INTERACTION; HUMAN; HYDROLYSIS; IMMUNE DEFICIENCY; IN VITRO STUDY; IN VIVO STUDY; MULTIGENE FAMILY; MYCOSIS; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN SECRETION; PROTEIN TARGETING; RECURRENT DISEASE; SHORT SURVEY; SYSTEMATIC REVIEW; SYSTEMIC MYCOSIS; TRANSCRIPTION REGULATION;

CANDIDA ALBICANS; CANDIDIASIS; FUNGAL PROTEINS; GENE EXPRESSION REGULATION, ENZYMOLOGIC; GENE EXPRESSION REGULATION, FUNGAL; HOST-PARASITE RELATIONS; HUMANS; MULTIGENE FAMILY; SERINE ENDOPEPTIDASES; TRANSCRIPTION, GENETIC;

CANDIDA; CANDIDA ALBICANS; FUNGI;

EID: 4544365934     PISSN: 14625814     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1462-5822.2004.00439.x     Document Type: Short Survey

References (109)

1. Albrecht, A., Felk, A., Pichova, I., Schaller, M., Kretschmar, M., Nichterlein, T., et al. (2004) Sap9 and Sap10 of Candida albicans: localization, function and their relevance for virulence. ASM Conference on Candida and Candidosis, 18-22 March 2004, Austin, Texas.
2. Bader, O., Schaller, M., Klein, S., Kukula, J., Haack, K., Mühlschlegel, F., et al. (2001) The KEX2 gene of Candida glabrata is required for cell surface integrity. Mol Microbiol 41: 1431-1444.
3. Barrett, A.J. (1980) Introduction: the classification of proteinases. In Symposium on Protein Degradation in Health and Disease (1979: Ciba Foundation). Amsterdam: Excerpta Medica, pp. 1-13.
4. Beausejour, A., Grenier, D., Goulet, J.P., and Deslauriers, N. (1998) Proteolytic activation of the interleukin-1 beta precursor by Candida albicans. Infect Immun 66: 676-681.
5. Beggah, S., Lechenne, U., Reichard, U., Foundling, S., and Monod, M. (2000) Intra- and intermolecular events direct the propeptide-mediated maturation of the Candida albicans secreted aspartic proteinase Sap1p. Microbiology 146: 2765-2773.
6. Bektic, J., Lell, C.P., Fuchs, A., Stoiber, H., Speth, C., Lass-Florl, C., et al. (2001) HIV protease inhibitors attenuate adherence of Candida albicans to epithelial cells in vitro. FEMS Immunol Med Microbiol 31: 65-71.
7. Borg-von Zepelin, M., Beggah, S., Boggian, K., Sanglard, D., and Monod, M. (1998) The expression of the secreted aspartyl proteinases Sap4 to Sap6 from Candida albicans in murine macrophages. Mol Microbiol 28: 543-554.
8. Borg-von Zepelin, M., Meyer, I., Thomssen, R., Würzner, R., Sanglard, D., Telenti, A., and Monod, M. (1999) HIV-Protease inhibitors reduce cell adherence of Candida albicans strains by inhibition of yeast secreted aspartic proteases. J Invest Dermatol 113: 747-751.
9. Brown, A.J.P. (2002a) Expression of growth-form specific factors during morphogenesis in Candida albicans. In Candida and Candidiasis. Calderone, R.A. (ed.). Washington, DC: American Society for Microbiology Press, pp. 87-93.
10. Brown, A.J.P. (2002b) Morphogenetic signaling pathways in Candida albicans. In Candida and Candidiasis. Calderone, R.A. (ed.). Washington, DC: American Society for Microbiology Press, pp. 95-106.
11. Brown, A.J., and Gow, N.A. (1999) Regulatory networks controlling Candida albicans morphogenesis. Trends Microbiol 7: 333-338.
12. de Bruin, D., Zaman, Z., Liberatore, R.A., and Ptashne, M. (2001) Telomere looping permits gene activation by a downstream UAS in yeast. Nature 409: 109-113.
13. Calderone, R.A., and Braun, P.C. (1991) Adherence and receptor relationships of Candida albicans. Microbiol Rev 55: 1-20.
14. Calderone, R., and Gow, N.A.R. (2002) Host recognition by Candida species. In Candida and Candidiasis. Calderone, R.A. (ed.). Washington, DC: American Society for Microbiology Press, pp. 67-86.
15. Caro, L.H., Tettelin, H., Vossen, J.H., van den Ram, A.F., Ende, H., and Klis, F.M. (1997) In silicio identification of glycosyl-phosphatidylinositol-anchored plasma-membrane and cell wall proteins of Saccharomyces cerevisiae. Yeast 13: 1477-1489.
16. Casadevall, A., Steenbergen, J.N., and Nosanchuk, J.D. (2003) 'Ready made' virulence and 'dual use' virulence factors in pathogenic environmental fungi - the Cryptococcus neoformans paradigm. Curr Opin Microbiol 6: 332-337.
17. Cassone, A., De Bernardis, F., Torosantucci, A., Tacconelli, E., Tumbarello, M., and Cauda, R. (1999) In vitro and in vivo anticandidal activity of human immunodeficiency virus protease inhibitors. J Infect Dis 180: 448-453.
18. Cassone, A., Tacconelli, E., De Bernardis, F., Tumbarello, M., Torosantucci, A., Chiani, P., and Cauda, R. (2002) Antiretroviral therapy with protease inhibitors has an early, immune reconstitution-independent beneficial effect on Candida virulence and oral candidiasis in human immunodeficiency virus-infected subjects. J Infect Dis 185: 188-195.
19. Chaffin, W.L., Lopez-Ribot, J.L., Casanova, M., Gozalbo, D., and Martinez, J.P. (1998) Cell wall and secreted proteins of Candida albicans: identification, function, and expression. Microbiol Mol Biol Rev 62: 130-180.
20. Colina, A.R., Aumont, F., Deslauriers, N., Belhumeur, P., and de Repentigny, L. (1996) Evidence for degradation of gastrointestinal mucin by Candida albicans secretory aspartyl proteinase. Infect Immun 64: 4514-4519.
21. Cunningham, E.L., and Agard, D.A. (2004) Disabling the folding catalyst is the last critical step in alpha-lytic protease folding. Protein Sci 13: 325-331.
22. Cutfield, S.M., Dodson, E.J., Anderson, B.F., Moody, P.C., Marshall, C.J., Sullivan, P.A., and Cutfield, J.F. (1995) The crystal structure of a major secreted aspartic proteinase from Candida albicans in complexes with two inhibitors. Structure 3: 1261-1271.
23. Davies, D.R. (1990) The structure and function of aspartic proteinases. Annu Rev Biophys Chem 19: 189-215.
24. De Bernardis, F., Boccanera, M., Adriani, D., Spreghini, E., Santoni, G., and Cassone, A. (1997) Protective role of antimannan and anti-aspartyl proteinase antibodies in an experimental model of Candida albicans vaginitis in rats. Infect Immun 65: 3399-3405.
25. De Bernardis, F., Arancia, S., Morelli, L., Hube, B., Sanglard, D., Schäfer, W., and Cassone, A. (1999) Evidence that members of the secretory aspartyl proteinase gene family, in particular SAP2, are virulence factors for Candida vaginitis. J Infect Dis 179: 201-208.
26. Ernst, J.F. (2000a) Regulation of dimorphism in Candida albicans. Contrib Microbiol 5: 98-111.
27. Ernst, J.F. (2000b) Transcription factors in Candida albicans - environmental control of morphogenesis. Microbiology 146: 1763-1774.
28. Felk, A., Schäfer, W., and Hube, B. (2000) Candida albicans secretory aspartic proteinase (SAP10) gene. Accession No. AF146440.
29. Felk, A., Kretschmar, M., Albrecht, A., Schaller, M., Beinhauer, S., Nichterlein, T., et al. (2002) Candida albicans hyphal formation and the expression of the Efg1-regulated proteinases Sap4 to Sap6 are required for the invasion of parenchymal organs. Infect Immun 70: 3689-3700.
30. Fidel, P.L., Jr, Vazquez, J.A., and Sobel, J.D. (1999) Candida glabrata: review of epidemiology, pathogenesis, and clinical disease with comparison to C. albicans. Clin Microbiol Rev 12: 80-96.
31. Garcia-Sanchez, S., Aubert, S., Iraqui, I., Janbon, G., Ghigo, J.M., and d'Enfert, C. (2004) Candida albicans biofilms: a developmental state associated with specific and stable gene expression patterns. Eukaryotic Cell 3: 536-545.
32. Germaine, G.R., and Tellefson, L.M. (1981) Effect of pH and human saliva on protease production by Candida albicans. Infect Immun 31: 323-326.
33. Gow, N.A.R., Brown, A.J.P., and Odds, F.C. (2002) Fungal morphogenesis and host invasion. Curr Opin Microbiol 5: 366-371.
34. von Heijne, G. (1985) Signal sequences. The limits of variation. J Mol Biol 184: 99-105.
35. Hostetter, M.K. (1994) Adhesins and ligands involved in the interaction of Candida spp. with epithelial and endothelial surfaces. Clin Mcrobiol Rev 7: 29-42.
36. Hube, B. (1996) Candida albicans secreted aspartyl proteinases. Curr Top Med Mycol 7: 55-69.
37. Hube, B. (2004) From commensal to pathogen: stage and tissue specific gene expression of Candida albicans. Curr Opin Microbiol 7: 1-6.
38. Hube, B., and Naglik, J. (2001) Candida albicans proteinases: resolving the mystery of a gene family. Microbiology 147: 1997-2005.
39. Hube, B., Turver, C.J., Odds, F.C., Eiffert, H., Boulnois, G.J., Kochel, H., and Rüchel, R. (1991) Sequence of the Candida albicans gene encoding the secretory aspartate proteinase. J Med Vet Mycol 29: 129-132.
40. Hube, B., Monod, M., Schofield, D.A., Brown, A.J.P., and Gow, N.A.R. (1994) Expression of seven members of the gene family encoding secretory aspartyl proteinases in Candida albicans. Mol Microbiol 14: 87-99.
41. Hube, B., Sanglard, D., Monod, M., Brown, A.J.P., and Gow, N.A.R. (1997a) Extracellular proteolytic activity of Candida species. In Proceedings of the Fifth Symposium on Topic in Mycology: Host-Fungus Interplay, Stanford, California, USA, June 27-30, 1995. Vanden Bossche, H., Stevens, D.A., and Odds, F.C. (eds). Bethesda: National Foundation for Infectious Diseases, pp. 109-122.
42. Hube, B., Sanglard, D., Odds, F.C., Hess, D., Monod, M., Schäfer, W., et al. (1997b) Disruption of each of the secreted aspartyl proteinase genes SAP1, SAP2, and SAP3 of Candida albicans attenuates virulence. Infect Immun 65: 3529-3538.
43. Jaswal, S.S., Sohl, J.L., Davis, J.H., and Agard, D.A. (2002) Energetic landscape of alpha-lytic protease optimizes longevity through kinetic stability. Nature 415: 343-346.
44. Julius, D., Brake, A., Blair, L., Kunisawa, R., and Thorner, J. (1984) Isolation of the putative structural gene for the lysine-arginine-cleaving endopeptidase required for processing of yeast prepro-alpha-factor. Cell 37: 1075-1089.
45. Kaminishi, H., Tanaka, M., Cho, T., Maeda, H., and Hagihara, Y. (1990) Activation of the plasma kallikrein-kinin system by Candida albicans proteinase. Infect Immun 58: 2139-2143.
46. Kaminishi, H., Hamatake, H., Cho, T., Tamaki, T., Suenaga, N., Fujii, T., et al. (1994) Activation of blood clotting factors by microbial proteinases. FEMS Microbiol Lett 176: 1702-1710.
47. Kaminishi, H., Miyaguchi, H., Tamaki, T., Suenaga, N., Hisamatsu, M., Mihashi, I., et al. (1995) Degradation of humoral host defense by Candida albicans proteinase. Infect Immun 63: 984-988.
48. Klemba, M., and Goldberg, D.E. (2002) Biological role of proteases in parasitic protozoa. Ann Rev Biochem 71: 275-305.
49. Koelsch, G., Tang, J., Loy, J.A., Monod, M., Jackson, K., Foundling, S.I., and Lin, X. (2000) Enzymic characteristics of secreted aspartic proteases of Candida albicans. Biochim Biophys Acta 1480: 117-131.
50. Komano, H., and Fuller, R.S. (1995) Shared functions in vivo of a glycosyl-phosphatidylinositol-linked aspartyl protease, Mkc7, and the proprotein processing protease Kex2 in yeast. Proc Natl Acad Sci USA 92: 10752-10756.
51. Korting, H.C., Schaller, M., Eder, G., Hamm, G., Bohmer, U., and Hube, B. (1999) Effects of the human immunodeficiency virus (HIV) proteinase inhibitors saquinavir and indinavir on in vitro activities of secreted aspartyl proteinases of Candida albicans isolates from HIV-infected patients. Antimicrob Agents Chemother 43: 2038-2042.
52. Korting, H., Hube, B., Oberbauer, S., Januschke, E., Hamm. G., Albrecht, A., et al. (2003) Reduced expression of the hyphal-independent Candida albicans proteinase genes SAP1 and SAP3 in the efg1 mutant is associated with attenuated virulence during infection of oral epithelium. J Med Microbiol 52: 623-632.
53. Kretschmar, M., Hube, B., Bertsch, T., Sanglard, D., Merker, R., Schroder, M., et al. (1999) Germ tubes and proteinase activity contribute to virulence of Candida albicans in murine peritonitis. Infect Immun 67: 6637-6642.
54. Kvaal, C., Lachke, S.A., Srikantha, T., Daniels, K., McCoy, J., and Soll, D.R. (1999) Misexpression of the opaque-phase-specific gene PEP1 (SAP1) in the white phase of Candida albicans confers increased virulence in a mouse model of cutaneous infection. Infect Immun 67: 6652-6662.
55. Langfelder, K., Streibel, M., Jahn, B., Haase, G., and Brakhage, A.A. (2003) Biosynthesis of fungal melanins and their importance for human pathogenic fungi. Fungal Genet Biol 38: 143-158.
56. Levine, M., and Tjian, R. (2003) Transcription regulation and animal diversity. Nature 424: 147-151.
57. Liu, H. (2001) Transcriptional control of dimorphism in Candida albicans. Curr Opin Microbiol 4: 728-735.
58. Monod, M., and Borg-von Zepelin, M. (2002) Secreted proteinases and other virulence mechanisms of Candida albicans. Chem Immunol 81: 114-128.
59. Monod, M., Togni, G., Hube, B., and Sanglard, D. (1994) Multiplicity of genes encoding secreted aspartic proteinases in Candida species. Mol Microbiol 13: 357-368.
60. Monod, M., Hube, B., Hess, D., and Sanglard, D. (1998) Differential regulation of SAP8 and SAP9, which encode two new members of the secreted aspartic proteinase family in Candida albicans. Microbiology 144: 2731-2737.
61. Morrow, B., Srikantha, T., and Soil, D.R. (1992) Transcription of the gene for a pepsinogen, PEP1, is regulated by white-opaque switching in Candida albicans. Mol Cell Biol 12: 2997-3005.
62. Morschhäuser, J., Virkola, R., Korhonen, T.K., and Hacker, J. (1997) Degradation of human subendothelial extracellular matrix by proteinase-secreting Candida albicans. FEMS Microbiol Lett 153: 349-355.
63. Murad, A.M., Leng, P., Straffon, M., Wishart, J., Macaskill, S., MacCallum, D., et al. (2001a) NRG1 represses yeast-hypha morphogenesis and hypha-specific gene expression in Candida albicans. EMBO J 20: 4742-4752.
64. Murad, A.M., d'Enfert, C., Gaillardin, C., Tournu, H., Tekaia, F., Talibi, D., et al. (2001b) Transcript profiling in Candida albicans reveals new cellular functions for the transcriptional repressors CaTup1, CaMig1 and CaNrg1. Mol Microbiol 42: 981-993.
65. Naglik, J.R., Newport, G., White, T.C., Fernandes-Naglik, L.L., Greenspan, J.S., Greenspan, D., et al. (1999) In vivo analysis of secreted aspartyl proteinase expression in human oral candidiasis. Infect Immun 67: 2482-2490.
66. Naglik, J.R., Challacombe, S.J., and Hube, B. (2003a) Candida albicans secreted aspartyl proteinases in virulence and pathogenesis. Microbiol Mol Biol Rev 67: 400-428.
67. Naglik, J.R., Rodgers, C.A., Shirlaw, P.J., Dobbie, J.L., Fernandes-Naglik, L.L., Greenspan, D., et al. (2003b) Differential expression of Candida albicans secreted aspartyl proteinase and phospholipase B genes in humans correlates with active oral and vaginal infections. J Infect Dis 188: 469-479.
68. Newport, G., and Agabian, N. (1997) KEX2 influences Candida albicans proteinase secretion and hyphal formation. J Biol Chem 272: 28954-28961.
69. Newport, G., Kuo, A., Flattery, A., Gill, C., Blake, J.J., Kurtz, M.B., et al. (2003) Inactivation of Kex2p diminishes the virulence of Candida albicans. J Biol Chem 278: 1713-1720.
70. Ogrydziak, D.M. (1993) Yeast extracellular proteases. Crit Rev Biotechnol 13: 1-55.
71. Peschel, A. (2002) How do bacteria resist human antimicrobial peptides? Trends Microbiol 10: 179-186.
72. Rasmussen, M., and Bjorck, L. (2002) Proteolysis and its regulation at the surface of Streptococcus pyogenes. Mol Microbiol 43: 537-544.
73. Ray, T.L., and Payne, C.D. (1988) Scanning electron microscopy of epidermal adherence and cavitation in murine candidiasis: a role for Candida acid proteinase. Infect Immun 56: 1942-1949.
74. Ray, T.L., Payne, C.D., Ruchel, R., Ritter, B., and Schaffrinski, M. (1990) Comparative production and rapid purification of Candida acid proteinase from protein-supplemented cultures. Infect Immun 273: 391-403.
75. Ripeau, J.S., Fiorillo, M., Aumont, F., Belhumeur, P., and de Repentigny, L. (2002) Evidence for differential expression of Candida albicans virulence genes during oral infection in intact and human immunodeficiency virus type 1-transgenic mice. J Infect Dis 185: 1094-1102.
76. Rosenthal, P.J. (2002) Hydrolysis of erythrocyte proteins by proteases of malaria parasites. Curr Opin Hematol 9: 140-145.
77. Rossetto, O., de Bernard, M., Pellizzari, R., Vitale, G., Caccin, P., Schiavo, G., and Montecucco, C. (2000) Bacterial toxins with intracellular protease activity. Clin Chim Acta 291: 189-199.
78. Rüchel, R. (1983) On the renin-like activity of Candida proteinases and activation of blood coagulation in vitro. Zentralbl Bakteriol Mikrobiol Hyg [A] 255: 368-379.
79. Rüchel, R. (1992) Proteinase. In New Strategies in Fungal Disease. Bennett, J.E., Hay, R.J., and Peterson, P.K. (eds). Edinburgh: Churchill Livingstone, pp. 17-31.
80. Rüchel, R., and Böning, B. (1983) Detection of Candida proteinase by enzyme immunoassay and interaction of the enzyme with α2-macroglobulin. J Immunol Methods 61: 107-116.
81. Rüchel, R., Zimmermann, F., Böning-Stutzer, B., and Helmchen, U. (1991) Candidiasis visualised by proteinase-directed immunofluorescence. Virch Arch a Pathol Anat 419: 199-202.
82. Ruhnke, M. (2002) Skin and mucous membrane infections. In Candida and Candidiasis. Calderone, R.A. (ed.). Washington, DC: American Society for Microbiology Press, pp. 307-325.
83. Sajid, M., and McKerrow, J.H. (2002) Cysteine proteases of parasitic organisms. Mol Biochem Parasitol 120: 1-21.
84. Sanglard, D., Hube, B., Monod, M., Odds, F.C., and Gow, N.A. (1997) A triple deletion of the secreted aspartyl proteinase genes SAP4, SAP5, and SAP6 of Candida albicans causes attenuated virulence. Infect Immun 65: 3539-3546.
85. Schaller, M., Schäfer, W., Korting, H.C., and Hube, B. (1998) Differential expression of secreted aspartyl proteinases in a model of human oral candidosis and in patient samples from the oral cavity. Mol Microbiol 29: 605-615.
86. Schaller, M., Hube, B., Ollert, M.W., Schäfer, W., Borg-von Zepelin, M., Thoma-Greber, E., and Korting, H.C. (1999a) In vivo expression and localization of Candida albicans secreted aspartyl proteinases during oral candidiasis in HIV-infected patients. J Invest Dermatol 112: 383-386.
87. Schaller, M., Korting, H.C., Schäfer, W., Bastert, J., Chen, W., and Hube, B. (1999b) Secreted aspartic proteinase (Sap) activity contributes to tissue damage in a model of human oral candidosis. Mol Microbiol 34: 169-180.
88. Schaller, M., Bein, M., Korting, H.C., Baur, S., Hamm, G., Monod, M., et al. (2003) The secreted aspartyl proteinases Sap1 and Sap2 cause tissue damage in an in vitro model of vaginal candidiasis based on reconstituted human vaginal epithelium. Infect Immun 71: 3227.
89. Schofield, D.A., Westwater, C., Warner, T., Nicholas, P.J., Paulling, E.E., and Balish, E. (2003) Hydrolytic gene expression during oroesophageal and gastric candidiasis in immunocompetent and immunodeficient gnotobiotic mice. J Infect Dis 188: 591-599.
90. Schweizer, A., Rupp, S., Taylor, B.N., Röllinghoff, M., and Schröppel, K. (2000) The TEA/ATTS transcription factor CaTec1p regulates hyphal development and virulence in Candida albicans. Mol Microbiol 38: 435-445.
91. Sobel, J.D. (1988) Pathogenesis and epidemiology of vulvovaginal candidiasis. Ann NY Acad Sci 544: 547-557.
92. Sobel, J.D. (1992) Pathogenesis and treatment of recurrent vulvovaginal candidiasis. Clin Infect Dis 14 (Suppl. 1): S148-S153.
93. Soll, D.R. (1992) High-frequency switching in Candida albicans. Clin Microbiol Rev 5: 183-203.
94. Soll, D.R. (1997) Gene regulation during high-frequency switching in Candida albicans. Microbiology 143: 279-288.
95. Soll, D.R. (2002) Phenotypic switching. In Candida and Candidiasis. Calderone R.A. (ed.). Washington, DC: American Society for Microbiology Press, pp. 123-142.
96. Soll, D.R., Morrow, B., Srikantha, T., Vargas, K., and Wertz, P. (1994) Developmental and molecular biology of switching in Candida albicans. Oral Surg Oral Med Oral Pathol 78: 194-201.
97. Staib, P., Kretschmar, M., Nichterlein, T., Hof, H., and Morschhäuser, J. (2000) Differential activation of a Candida albicans virulence gene family during infection. Proc Natl Acad Sci USA 97: 6102-6107.
98. Staib, P., Kretschmar, M., Nichterlein, T., Hof, H., and Morschhäuser, J. (2002) Host versus in vitro signals and intrastrain allelic differences in the expression of a Candida albicans virulence gene. Mol Microbiol 44: 1351-1366.
99. Sundstrom, P. (1999) Adhesins in Candida albicans. Curr Opin Microbiol 2: 353-357.
100. Sundstrom, P. (2002) Adhesion in Candida spp. Cell Microbiol 4: 461-469.
101. Sweet, S.P. (1997) Selection and pathogenicity of Candida albicans in HIV infection. Oral Dis 3: S88-S95.
102. Tsushima, H., and Mine, H. (1995) Cleavage of human big endothelin-1 by Candida albicans aspartic proteinase. FEMS Immunol Med Microbiol 11: 69-72.
103. Tsushima, H., Mine, H., Kawakami, Y., Hyodoh, F., and Ueki, A. (1994) Candida albicans aspartic proteinase cleaves and inactivates human epidermal cysteine proteinase inhibitor, cystatin A. Microbiology 140: 167-171.
104. Vilanova, M., Teixeira, L., Caramalho, I., Torrado, E., Marques, A., Madureira, P., et al. (2004) Protection against systemic candidiasis in mice immunized with secreted aspartic proteinase 2. Immunology 111: 334-342.
105. Watts, H.J., Cheah, F.S., Hube, B., Sanglard, D., and Gow, N.A. (1998) Altered adherence in strains of Candida albicans harbouring null mutations in secreted aspartic proteinase genes. FEMS Microbiol Lett 159: 129-135.
106. White, T.C., and Agabian, N. (1995) Candida albicans secreted aspartyl proteinases: isoenzyme pattern is determined by cell type, and levels are determined by environmental factors. J Bacteriol 177: 5215-5221.
107. White, T.C., Miyasaki, S.H., and Agabian, N. (1993) Three distinct secreted aspartyl proteinases in Candida albicans. J Bacteriol 175: 6126-6133.
108. Wyrick, J.J., and Young, R.A. (2002) Deciphering gene expression regulatory networks. Curr Opin Genet Dev 12: 130-136.
109. Yao, C., Donelson, J.E., and Wilson, M.E. (2003) The major surface protease (MSP or GP63) of Leishmania sp. Biosynthesis, regulation of expression, and function. Mol Biochem Parasitol 132: 1-16.